- •To compare from dosimetric and equivalent doses point of view, SABR plans of lung cancer patients from 26 centers.
- •To compare plans with various TPS’s, delivery technologies and dose normalization approaches.
- •To analyze the gEUD2, MLD2 and constraints fulfillment against planner expertise and involved technology.
A large-scale multi-institutional planning comparison on lung cancer SABR is presented with the aim of investigating possible criticism in carrying out retrospective multicentre data analysis from a dosimetric perspective.
Five CT series were sent to the participants. The dose prescription to PTV was 54 Gy in 3 fractions of 18 Gy. The plans were compared in terms of PTV-gEUD2 (generalized Equivalent Uniform Dose equivalent to 2 Gy), mean dose to PTV, Homogeneity Index (PTV-HI), Conformity Index (PTV-CI) and Gradient Index (PTV-GI). We calculated the maximum dose for each OAR (organ at risk) considered as well as the MLD2 (mean lung dose equivalent to 2 Gy). The data were stratified according to expertise and technology.
Twenty-six centers equipped with Linacs, 3DCRT (4% – 1 center), static IMRT (8% – 2 centers), VMAT (76% – 20 centers), CyberKnife (4% – 1 center), and Tomotherapy (8% – 2 centers) collaborated. Significant PTV-gEUD2 differences were observed (range: 105–161 Gy); mean-PTV dose, PTV-HI, PTV-CI, and PTV-GI were, respectively, 56.8 ± 3.4 Gy, 14.2 ± 10.1%, 0.70 ± 0.15, and 4.9 ± 1.9. Significant correlations for PTV-gEUD2 versus PTV-HI, and MLD2 versus PTV-GI, were observed.
The differences in terms of PTV-gEUD2 may suggest the inclusion of PTV-gEUD2 calculation for retrospective data inter-comparison.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Physica Medica: European Journal of Medical Physics
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Factors associated with decisions to undergo surgery among patients with newly diagnosed early stage lung cancer.J Am Med Assoc. 2010; 303: 2368-2376
- Stereotactic hypofractionated high-dose irradiation for stage I non small cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study.Cancer. 2004; 101: 1623-1631
- Outcome in a prospective phase II trial of medically inoperable stage I non small-cell lung cancer patients treated with stereotactic body radiotherapy.J Clin Oncol. 2009; 27: 3290-3296
- Stereotactic body radiation therapy for inoperable early stage lung cancer.J Am Med Assoc. 2010; 303: 1070-1076
- Intensity modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.J Natl Cancer Inst. 2008; 100: 300-307
- A Feasibility dosimetric study on prostate cancer: are we ready for a multicenter clinical trial on SBRT?.Strahlenther Onkol. 2015; 191: 573-581
- Stereotactic body radiation therapy: the report of AAPM task group 101.Med Phys. 2010; 37: 4078-4101
- Reporting and analyzing dose distributions: a concept of equivalent uniform dose.Med Phys. 1997; 24: 103-110
- A free program for calculating Eud-based Ntcp and Tcp in external beam radiotherapy.Phys Med. 2007; 23: 115-257
- Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.Acta Oncol. 2008; 27: 1-7
- Analysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapy.Pract Radiat Oncol. 2011; 2: 46-53
- Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer.Int J Radiat Oncol Biol Phys. 2007; 68: 416-425
- Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403).Phys Med Biol. 2006; 51: 5409-5417
- Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02.J Clin Oncol. 2010; 28: 2996-3001
- Multicentre treatment planning inter-comparison in a national context: the liver stereotactic ablative radiotherapy case.Phys Med. 2016; 32: 277-283
- Optimizing dose prescription in stereotactic body radiotherapy for lung tumours using Monte Carlo dose calculation.Radiother Oncol. 2010; 94: 42-46
- ICRU report 62: prescribing, recording, and reporting photon beam therapy (Supplement to ICRU Report 50).1999
- ICRU report 83: prescribing, recording, and reporting photon-beam intensity modulated radiation therapy (IMRT).J ICRU. 2010; 10: 1-10
- How should we describe the radiobiologic effect of extracranial stereotactic radiosurgery: equivalent uniform dose or tumor control probability?.Med Phys. 2003; 30: 321-324
- A challenge to traditional radiation oncology.Int J Radiat Oncol Biol Phys. 2004; 60: 1241-1256
- Observation of a dose–control relationship for lung and liver tumors after stereotactic body radiation therapy.Int J Radiat Oncol Biol Phys. 2009; 73: 112-118
- Study of 201 non small cell lung cancer patients given stereotactic ablative radiation therapy shows local control dependence on dose calculation algorithm.Int J Radiat Oncol Biol Phys. 2014; 88: 1108-1113
- Modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC).Med Phys. 2012; 39: 4502-4514
- Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.J Clin Oncol. 2006; 24: 4833-4839
- Normal tissue toxicity after small field hypofractionated stereotactic body radiation.Radiat Oncol. 2008; 3: 36
- Hypofractionation, long-term effects, and the alpha/beta ratio.Int J Radiat Oncol Biol Phys. 2008; 72: 11-12
- The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: implications for tumour coverage.Radiother Oncol. 2009; 91: 405-414
- Algorithms used in heterogeneous dose calculations show systematic differences as measured with the radiological physics center’s anthropomorphic thorax phantom used for RTOG credentialing.Int J Radiat Oncol Biol Phys. 2013; 85: e95-e100
- Accuracy of dose calculation algorithms for static and rotational IMRT of lung cancer: a phantom study.Phys Med. 2015; 31: 382-390
Published online: April 06, 2016
Accepted: March 19, 2016
Received in revised form: March 15, 2016
Received: December 24, 2015
© 2016 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.